Page last updated: 2024-08-21

nandrolone and raloxifene hydrochloride

nandrolone has been researched along with raloxifene hydrochloride in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Godekmerdan, A; Kumru, S; Kutlu, S; Yildiz, MF	1
Godekmerdan, A; Gurates, B; Kumru, S; Kutlu, S; Yildiz, FM; Yilmaz, B	1
Frassetto, LA; Gordon, PL	1

Reviews

1 review(s) available for nandrolone and raloxifene hydrochloride

Article	Year
Management of osteoporosis in CKD Stages 3 to 5. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2010, Volume: 55, Issue:5 Topics: Absorptiometry, Photon; Accidental Falls; Aged; Animals; Bone Density; Bone Density Conservation Agents; Calcitonin; Comorbidity; Diphosphonates; Female; Glomerular Filtration Rate; Humans; Life Style; Magnetic Resonance Imaging; Muscle Strength; Nandrolone; Nandrolone Decanoate; Nitric Oxide; Osteoporosis; Parathyroid Hormone; Phosphates; Raloxifene Hydrochloride; Renal Insufficiency, Chronic; Selective Estrogen Receptor Modulators; Teriparatide; Tomography, X-Ray Computed; Vitamin D Deficiency	2010

Article

Year

Management of osteoporosis in CKD Stages 3 to 5.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2010, Volume: 55, Issue:5

Topics: Absorptiometry, Photon; Accidental Falls; Aged; Animals; Bone Density; Bone Density Conservation Agents; Calcitonin; Comorbidity; Diphosphonates; Female; Glomerular Filtration Rate; Humans; Life Style; Magnetic Resonance Imaging; Muscle Strength; Nandrolone; Nandrolone Decanoate; Nitric Oxide; Osteoporosis; Parathyroid Hormone; Phosphates; Raloxifene Hydrochloride; Renal Insufficiency, Chronic; Selective Estrogen Receptor Modulators; Teriparatide; Tomography, X-Ray Computed; Vitamin D Deficiency

2010

Trials

2 trial(s) available for nandrolone and raloxifene hydrochloride

Article	Year
Effects of raloxifene, hormone therapy, and soy isoflavone on serum high-sensitive C-reactive protein in postmenopausal women. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2005, Volume: 90, Issue:2 Topics: C-Reactive Protein; Cholesterol; Estradiol; Estrogen Replacement Therapy; Female; Glycine max; Humans; Isoflavones; Lipoproteins; Middle Aged; Nandrolone; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Treatment Outcome	2005
Effects of raloxifene and hormone replacement therapy on serum Th2 and Th3 type cytokine concentrations in healthy postmenopausal women: a randomised controlled trial. Archives of gynecology and obstetrics, 2008, Volume: 277, Issue:6 Topics: Bone Density Conservation Agents; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Interleukin-4; Middle Aged; Nandrolone; Postmenopause; Raloxifene Hydrochloride; Single-Blind Method; T-Lymphocytes, Regulatory; Th2 Cells; Transforming Growth Factor beta1	2008

Article

Year

Effects of raloxifene, hormone therapy, and soy isoflavone on serum high-sensitive C-reactive protein in postmenopausal women.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2005, Volume: 90, Issue:2

Topics: C-Reactive Protein; Cholesterol; Estradiol; Estrogen Replacement Therapy; Female; Glycine max; Humans; Isoflavones; Lipoproteins; Middle Aged; Nandrolone; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Treatment Outcome

2005

Effects of raloxifene and hormone replacement therapy on serum Th2 and Th3 type cytokine concentrations in healthy postmenopausal women: a randomised controlled trial.

Archives of gynecology and obstetrics, 2008, Volume: 277, Issue:6

Topics: Bone Density Conservation Agents; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Interleukin-4; Middle Aged; Nandrolone; Postmenopause; Raloxifene Hydrochloride; Single-Blind Method; T-Lymphocytes, Regulatory; Th2 Cells; Transforming Growth Factor beta1

2008